Similar articles

• Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction.

  Lim KB, Ho H, Foo KT, Wong MY, Fook-Chong S. Lim KB, et al. Int J Urol. 2006 Dec;13(12):1509-13. doi: 10.1111/j.1442-2042.2006.01611.x. Int J Urol. 2006. PMID: 17118026
• Prostate-specific antigen: could it be a useful marker for bladder outlet obstruction?

  Speakman MJ. Speakman MJ. Eur Urol. 2008 Dec;54(6):1223-5. doi: 10.1016/j.eururo.2008.07.028. Epub 2008 Jul 16. Eur Urol. 2008. PMID: 18675505 No abstract available.
• The relation of lower urinary tract symptoms with life-style factors and objective measures of benign prostatic enlargement and obstruction: an Italian survey.

  Kaplan SA. Kaplan SA. J Urol. 2005 Jun;173(6):2058. doi: 10.1097/01.ju.0000161238.83624.67. J Urol. 2005. PMID: 15879832 No abstract available.
• The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia.

  Roehrborn CG. Roehrborn CG. Int J Impot Res. 2008 Dec;20 Suppl 3:S19-26. doi: 10.1038/ijir.2008.53. Int J Impot Res. 2008. PMID: 19002120 Review.
• Pathology of benign prostatic hyperplasia.

  Roehrborn CG. Roehrborn CG. Int J Impot Res. 2008 Dec;20 Suppl 3:S11-8. doi: 10.1038/ijir.2008.55. Int J Impot Res. 2008. PMID: 19002119 Review.